Sharing R&D Risk in Healthcare via FDA Hedges
收藏NBER2017-05-01 更新2025-01-04 收录
下载链接：
https://www.nber.org/papers/w23344
下载链接
链接失效反馈官方服务：
资源简介：
The high cost of capital for firms conducting medical research and development (R&D) has been partly attributed to the government risk facing investors in medical innovation. This risk slows down medical innovation because investors must be compensated for it. We analyze new and simple financial
提供机构：
美国国家经济研究局
创建时间：
2017-05-01
